Literature DB >> 34396410

Gonococcal Pelvic Inflammatory Disease: Placing Mechanistic Insights Into the Context of Clinical and Epidemiological Observations.

Stacey X Xu1, Scott D Gray-Owen1.   

Abstract

While infection by Neisseria gonorrhoeae is often asymptomatic in women, undetected infections can ascend into the upper genital tract to elicit an inflammatory response that manifests as pelvic inflammatory disease, with the outcomes depending on the intensity and duration of inflammation and whether it is localized to the endometrial, fallopian tube, ovarian, and/or other tissues. This review examines the contribution of N. gonorrhoeae versus other potential causes of pelvic inflammatory disease by considering new insights gained through molecular, immunological, and microbiome-based analyses, and the current epidemiological burden of infection, with an aim to highlighting key areas for future study.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Neisseria gonorrhoeaezzm321990 ; cervicitis; endometrial infection; endometritis; gonorrhea; neutrophil; oophoritis; pelvic inflammatory disease (PID); salpingitis

Mesh:

Year:  2021        PMID: 34396410      PMCID: PMC8365115          DOI: 10.1093/infdis/jiab227

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  49 in total

Review 1.  Neisseria gonorrhoeae host adaptation and pathogenesis.

Authors:  Sarah Jane Quillin; H Steven Seifert
Journal:  Nat Rev Microbiol       Date:  2018-02-12       Impact factor: 60.633

Review 2.  An overview of infectious agents of salpingitis, their biology, and recent advances in methods of detection.

Authors:  P A Mårdh
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

Review 3.  Animal models for studying female genital tract infection with Chlamydia trachomatis.

Authors:  Evelien De Clercq; Isabelle Kalmar; Daisy Vanrompay
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

Review 4.  Human experimentation with Neisseria gonorrhoeae: progress and goals.

Authors:  M S Cohen; J G Cannon
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

5.  Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin.

Authors:  J N Wasserheit; T A Bell; N B Kiviat; P Wølner-Hanssen; V Zabriskie; B D Kirby; E C Prince; K K Holmes; W E Stamm; D A Eschenbach
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

6.  Crucial role of neutrophils in the development of mechanical inflammatory hypernociception.

Authors:  Thiago M Cunha; Waldiceu A Verri; Ieda R Schivo; Marcelo H Napimoga; Carlos A Parada; Stephen Poole; Mauro M Teixeira; Sergio H Ferreira; Fernando Q Cunha
Journal:  J Leukoc Biol       Date:  2008-01-18       Impact factor: 4.962

7.  Polymicrobial etiology of acute pelvic inflammatory disease.

Authors:  D A Eschenbach; T M Buchanan; H M Pollock; P S Forsyth; E R Alexander; J S Lin; S P Wang; B B Wentworth; W M MacCormack; K K Holmes
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

8.  Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa.

Authors:  C R Gregg; M A Melly; C G Hellerqvist; J G Coniglio; Z A McGee
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

Review 9.  Gonococcal infections.

Authors:  E W Hook; K K Holmes
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

10.  Global analysis of neutrophil responses to Neisseria gonorrhoeae reveals a self-propagating inflammatory program.

Authors:  Anna Sintsova; Helen Sarantis; Epshita A Islam; Chun Xiang Sun; Mohsen Amin; Carlos H F Chan; Clifford P Stanners; Michael Glogauer; Scott D Gray-Owen
Journal:  PLoS Pathog       Date:  2014-09-04       Impact factor: 6.823

View more
  1 in total

1.  Screening for Chlamydia and Gonorrhea.

Authors:  Jeanne Marrazzo; Jodie Dionne-Odom
Journal:  JAMA       Date:  2021-09-14       Impact factor: 157.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.